HMOX2 and ovarian carcinoma: HMOX2, ICMT, MICU1, and TSPAN9 also positively correlated with CD73_1 and CD73_2 densities and short survival and have been shown to be involved in conferring chemoresistance in ovarian cancer [56,57,58,59] (Table S4, Figure S6).